Larvol Delta - Atsena-Therapeutics-Receives-Orphan-Drug-Designation-from-the-US-FDA-for-ATSN201-Gene-Therapy-to-Treat-Xlinked-Retinoschisis

ATSN-201 - Atsena Therap

https://www.globenewswire.com/news-release/2024/09/17/2947307/0/en/Atsena-Therapeutics-Receives-Orphan-Drug-Designation-from-the-U-S-FDA-for-ATSN-201-Gene-Therapy-to-Treat-X-linked-Retinoschisis.html

Sep 17, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next